Related Experiment Videos
[Screening and intervention. A strategy in type 2 diabetes?].
Torben Jørgensen1, Charlotte Glümer, Knut Borch-Johnsen
1Center for Sygdomsforebyggelse, Opgang 8. 7. sal, Amtssygehuset i Glostrup, DK-2600 Glostrup.
Ugeskrift for Laeger
|May 7, 2002
Summary
Systematic screening for type 2 diabetes lacks evidence for improving health outcomes. Further research and improved care for diagnosed patients are recommended before widespread implementation.
Area of Science:
- Endocrinology
- Public Health
- Health Services Research
Context:
- Type 2 diabetes is a growing global health concern.
- Current literature lacks robust evidence on the benefits of systematic screening.
- Existing economic models suggest opportunistic screening may be more cost-effective.
Purpose:
- To evaluate the multifaceted aspects of introducing type 2 diabetes screening.
- To assess the evidence regarding the impact of screening on morbidity and mortality.
- To review patient perspectives and economic consequences of screening methods.
Summary:
- A literature review indicates a lack of randomized clinical trials demonstrating that systematic screening improves type 2 diabetes outcomes.
- Screening methodologies require optimization, and patient perspectives are underrepresented in current research.
- Economic analyses favor opportunistic screening, but conclusions are uncertain due to limited trial data.
Impact:
- A decision on systematic type 2 diabetes screening should be deferred pending results from ongoing randomized clinical trials.
- Focus should shift to enhancing care quality for individuals already diagnosed with type 2 diabetes.
- This research highlights critical gaps in evidence needed for effective public health policy development.